A carregar...
Rituximab for Refractory Wegener's Granulomatosis: Report of a Prospective, Open-Label Pilot Trial
Rationale: Standard therapy for Wegener's granulomatosis is fraught with substantial toxicity and not always effective. B lymphocytes have been implicated in the pathogenesis of Wegener's granulomatosis. Their depletion has been proposed as salvage therapy for refractory disease. Earlier e...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Thoracic Society
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2662987/ https://ncbi.nlm.nih.gov/pubmed/16224107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.200507-1144OC |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|